Why We Invested In Transcera — Ceramide Therapeutic Platform

Excited to announce our investment in the seed for Transcera, a biotech company developing a ceramide lipid-based drug delivery platform that utilizes active transport pathways to increase drug absorption. We are joined by Xora Innovation, an early-stage deep tech investment platform of Temasek, Digitalis Ventures, Pear VC, and KdT Ventures. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in mature seed, typically when there is a pipeline of customers. We found Transcera to be exciting for several reasons: (1) big need (2) high-caliber team and (3) product opportunity. 1) The Need A key factor in dosing for biologic drugs used for prevalent…...